File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Scopus: eid_2-s2.0-34347391938
- PMID: 17584042
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: The metabolic syndrome and vascular disease in Asia
Title | The metabolic syndrome and vascular disease in Asia |
---|---|
Authors | |
Keywords | Chemicals And Cas Registry Numbers |
Issue Date | 2007 |
Publisher | Bentham Science Publishers Ltd. The Journal's web site is located at http://www.bentham.org/cdtchd |
Citation | Cardiovascular And Hematological Disorders - Drug Targets, 2007, v. 7 n. 2, p. 79-85 How to Cite? |
Abstract | The metabolic syndrome is a constellation of vascular disease risk factors that includes hyperglycaemia, hypertension, and dyslipidaemia, which are largely mediated by accumulating fat depots, particularly when centrally deposited. Increasing adiposity promotes insulin resistance, low grade inflammation and endothelial dysfunction, which promote the development of atherogenic vascular disease. Increases in percentage body fat result from a number of parameters, including ageing, and changes in lifestyle factors that promote a metabolic imbalance, such as decreasing physical activity and adverse dietary patterns. As Asian populations continue to modernize, levels of physical activity are declining as home and workplace jobs become more automated and sedentary and transportation more readily available. Similarly, dietary changes are introduced, with healthy traditional plant-based diets being replaced by cheaper calorie dense high fat foods. These changes are resulting in rapid increases in the prevalence of obesity throughout Asia, and the subsequent development of the metabolic syndrome. To minimise further development of the obesity pandemic and subsequent vascular disease, innovative population-based preventative lifestyle and therapeutic strategies interventions need to be introduced. © 2007 Bentham Science Publishers Ltd. |
Persistent Identifier | http://hdl.handle.net/10722/91420 |
ISSN | 2023 SCImago Journal Rankings: 0.258 |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cheung, BMY | en_HK |
dc.contributor.author | Thomas, GN | en_HK |
dc.date.accessioned | 2010-09-17T10:19:05Z | - |
dc.date.available | 2010-09-17T10:19:05Z | - |
dc.date.issued | 2007 | en_HK |
dc.identifier.citation | Cardiovascular And Hematological Disorders - Drug Targets, 2007, v. 7 n. 2, p. 79-85 | en_HK |
dc.identifier.issn | 1871-529X | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/91420 | - |
dc.description.abstract | The metabolic syndrome is a constellation of vascular disease risk factors that includes hyperglycaemia, hypertension, and dyslipidaemia, which are largely mediated by accumulating fat depots, particularly when centrally deposited. Increasing adiposity promotes insulin resistance, low grade inflammation and endothelial dysfunction, which promote the development of atherogenic vascular disease. Increases in percentage body fat result from a number of parameters, including ageing, and changes in lifestyle factors that promote a metabolic imbalance, such as decreasing physical activity and adverse dietary patterns. As Asian populations continue to modernize, levels of physical activity are declining as home and workplace jobs become more automated and sedentary and transportation more readily available. Similarly, dietary changes are introduced, with healthy traditional plant-based diets being replaced by cheaper calorie dense high fat foods. These changes are resulting in rapid increases in the prevalence of obesity throughout Asia, and the subsequent development of the metabolic syndrome. To minimise further development of the obesity pandemic and subsequent vascular disease, innovative population-based preventative lifestyle and therapeutic strategies interventions need to be introduced. © 2007 Bentham Science Publishers Ltd. | en_HK |
dc.language | eng | en_HK |
dc.publisher | Bentham Science Publishers Ltd. The Journal's web site is located at http://www.bentham.org/cdtchd | en_HK |
dc.relation.ispartof | Cardiovascular and Hematological Disorders - Drug Targets | en_HK |
dc.subject | Chemicals And Cas Registry Numbers | en_HK |
dc.subject.mesh | Abdominal Fat - physiology | en_HK |
dc.subject.mesh | Animals | en_HK |
dc.subject.mesh | Asia - epidemiology | en_HK |
dc.subject.mesh | Disease Outbreaks | en_HK |
dc.subject.mesh | Humans | en_HK |
dc.subject.mesh | Metabolic Syndrome X - epidemiology | en_HK |
dc.subject.mesh | Obesity - epidemiology | en_HK |
dc.subject.mesh | Vascular Diseases - epidemiology | en_HK |
dc.title | The metabolic syndrome and vascular disease in Asia | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Cheung, BMY:mycheung@hku.hk | en_HK |
dc.identifier.authority | Cheung, BMY=rp01321 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.pmid | 17584042 | - |
dc.identifier.scopus | eid_2-s2.0-34347391938 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-34347391938&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 7 | en_HK |
dc.identifier.issue | 2 | en_HK |
dc.identifier.spage | 79 | en_HK |
dc.identifier.epage | 85 | en_HK |
dc.publisher.place | Netherlands | en_HK |
dc.identifier.scopusauthorid | Cheung, BMY=7103294806 | en_HK |
dc.identifier.scopusauthorid | Thomas, GN=35465269900 | en_HK |
dc.identifier.issnl | 1871-529X | - |